Commentary | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Commentary
With legalization looming, cannabis companies need to prepare responsible marketing guidelines
By
Kurt Schmidt
July 30, 2021
Commentary
What the NFL’s vaccination policy says about the inescapability of politics
By
Tim Elcombe
July 29, 2021
Commentary
The bipartisan infrastructure bill could be a big victory for business
By
Jeffrey Sonnenfeld
July 29, 2021
Commentary
Robinhood’s IPO marks a sea change in finance
By
Jan Hammer
July 29, 2021
Commentary
Why gamified trading is good for the stock market
By
Erik Gordon
July 28, 2021
Commentary
The Delta variant surge shows the folly of a normal return to office
By
Gleb Tsipursky
July 27, 2021
Commentary
How new technologies are transforming cancer treatment
By
Paul Hudson
July 26, 2021
Commentary
How U.S. CEOs can stand up to China
By
Nick Merrill
and
Dan Schwerin
July 26, 2021
Finance
Waiting for the ‘normal’ stock market to return? Don’t hold your breath
By
Ben Carlson
July 25, 2021
Commentary
What ‘Ted Lasso’ can teach you about leadership
By
Galit Feinreich
July 23, 2021
Commentary
After COVID, keeping employees healthy is the next great challenge for CEOs
By
Arnaud Vaissié
July 22, 2021
Commentary
Wall Street is boosting profits in railroads with new technology. But it’s ignoring the drawbacks
By
Peter DeFazio
July 21, 2021
Commentary
Philip Morris International is getting into inhalable medicine. Is it a PR stunt?
By
Darrin Duber-Smith
July 20, 2021
Commentary
The West doesn’t need Chinese tech to fight climate change
By
Denis Payre
July 20, 2021

1 - 14 of 5,871 results

1 - 14 of 5,871 results